News | tctmd.com

In-Depth

See all

Feature

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

By Yael L. Maxwell

Conference News

AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

By Shelley Wood

News

FDA Approves Icosapent Ethyl for Reducing CVD Events

The prescription-grade fish oil received the expanded claim following the positive REDUCE-IT results.

By Michael O'Riordan

December 13, 2019

FDA Approves Icosapent Ethyl for Reducing CVD Events

Feature

Year in Review: In Imaging, Interventional CT, Physiology, and #SoMe Advance in 2019

No one blockbuster study shook up the field of imaging over the past year, but it has been otherwise futuristic.

December 13, 2019

Year in Review: In Imaging, Interventional CT, Physiology, and #SoMe Advance in 2019

News

Hypothermia Boosts 90-Day Function for Nonshockable Cardiac Arrest

Although there wasn’t a survival benefit in the RCT, neurological outcomes of these challenging patients were much improved.

By Caitlin E. Cox

December 13, 2019

Hypothermia Boosts 90-Day Function for Nonshockable Cardiac Arrest

News

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

In a mendelian analysis, low Lp(a) levels also were linked to diabetes, but treatment can still be done safely, say researchers.

By Yael L. Maxwell

December 12, 2019

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

Feature • Interventional

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

(UPDATED) The 3,500-word rebuttal addresses the “misleading narrative” impugning the trial’s conduct, spawned by a BBC investigation.

By Michael O'Riordan

December 12, 2019

EXCEL Investigators Respond to Data Suppression Claims As Debate Erupts Online

Feature

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

A widely-criticized meta-analysis led to town halls and FDA advisory meetings, with no resolution of the mortality signal.

By L.A. McKeown

December 12, 2019

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

News

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

The information from these measurements “may be more useful to cardiologists” than treadmill exercise tests, one author says.

By Yael L. Maxwell

December 11, 2019

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Rox Heart Radio

Cath Lab Calamities

News

FDA Advisors Decline to Recommend Vernakalant Approval

The IV antiarrhythmic, intended for conversion of new-onset A-fib, is approved outside the US. Here, advisors are still wary.

By Shelley Wood

December 11, 2019

FDA Advisors Decline to Recommend Vernakalant Approval

News

Anticoagulation Prescription in the ED May Boost Later Use

Short-term prescriptions may help overcome emergency physicians’ hesitation about initiating therapy, experts say.

By Todd Neale

December 11, 2019

Anticoagulation Prescription in the ED May Boost Later Use

News • Interventional

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Women merit more focus in research and don’t represent a homogeneous population, editorialists urge.

By Caitlin E. Cox

December 11, 2019

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

News

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

Poor functional capacity on stress echocardiography was also linked with deaths from cancer and other causes, new data show.

By Michael O'Riordan

December 10, 2019

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

See All News

Advertisement

In-Depth

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

FDA Approves Icosapent Ethyl for Reducing CVD Events

Year in Review: In Imaging, Interventional CT, Physiology, and #SoMe Advance in 2019

Hypothermia Boosts 90-Day Function for Nonshockable Cardiac Arrest

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Cath Lab Calamities

FDA Advisors Decline to Recommend Vernakalant Approval

Anticoagulation Prescription in the ED May Boost Later Use

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

Advertisement

@tctmd

Upcoming Conferences

CTO 2020

Conference Coverage

TVT 2019

ESC Congress 2019

EuroPCR 2019

Around the Web

Advertisement

Advertisement

In-Depth

Search News

Never miss a beat

Advertisement

@tctmd

Upcoming Conferences

Conference Coverage

Around the Web

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content